ATE451382T1 - 4-substituierte-3,6-anhydro-galaktosederivate und ihre pharmazeutische verwendung - Google Patents

4-substituierte-3,6-anhydro-galaktosederivate und ihre pharmazeutische verwendung

Info

Publication number
ATE451382T1
ATE451382T1 AT00900420T AT00900420T ATE451382T1 AT E451382 T1 ATE451382 T1 AT E451382T1 AT 00900420 T AT00900420 T AT 00900420T AT 00900420 T AT00900420 T AT 00900420T AT E451382 T1 ATE451382 T1 AT E451382T1
Authority
AT
Austria
Prior art keywords
anhydro
substituted
pharmaceutical use
galactose derivatives
substituent
Prior art date
Application number
AT00900420T
Other languages
English (en)
Inventor
Eiji Kobayashi
Tuo-Ping Li
Tatsuji Enoki
Takanari Tominaga
Hiroaki Sagawa
Ikunoshin Kato
Original Assignee
Takara Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takara Bio Inc filed Critical Takara Bio Inc
Application granted granted Critical
Publication of ATE451382T1 publication Critical patent/ATE451382T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/10—Anhydrosugars, e.g. epoxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT00900420T 1999-01-20 2000-01-18 4-substituierte-3,6-anhydro-galaktosederivate und ihre pharmazeutische verwendung ATE451382T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1164199 1999-01-20
JP26711199 1999-09-21
PCT/JP2000/000185 WO2000043407A1 (en) 1999-01-20 2000-01-18 Remedies

Publications (1)

Publication Number Publication Date
ATE451382T1 true ATE451382T1 (de) 2009-12-15

Family

ID=26347108

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00900420T ATE451382T1 (de) 1999-01-20 2000-01-18 4-substituierte-3,6-anhydro-galaktosederivate und ihre pharmazeutische verwendung

Country Status (10)

Country Link
US (1) US6518302B1 (de)
EP (1) EP1146050B1 (de)
JP (1) JP4145494B2 (de)
KR (1) KR100593393B1 (de)
CN (1) CN1210285C (de)
AT (1) ATE451382T1 (de)
AU (1) AU2005400A (de)
DE (1) DE60043497D1 (de)
TW (1) TWI290144B (de)
WO (1) WO2000043407A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA004148B1 (ru) * 1997-11-11 2004-02-26 Такара Сузо Ко., Лтд Фармацевтическая композиция на основе 3,6-ангидрогалактопиранозы, и/или ее производных, и/или растворимого сахарида, содержащего данное соединение, применение композиции и входящих в ее состав ингредиентов, пищевой продукт, содержащий указанную композицию, и применение пищевого продукта
AU2001294173A1 (en) * 2000-10-03 2002-04-15 Takara Bio Inc. Method of screening physiologically active substance
US20040077845A1 (en) * 2001-02-20 2004-04-22 Tatsuji Enoki Modifier
JP2003073266A (ja) * 2001-08-30 2003-03-12 Osaka Organic Chem Ind Ltd 癌細胞増殖阻害剤
TW200403067A (en) * 2002-04-17 2004-03-01 Takara Bio Inc Remedies
WO2008047663A1 (en) * 2006-10-16 2008-04-24 Takara Bio Inc. Activity enhancer for detoxifying enzyme
US20080268025A1 (en) * 2007-04-25 2008-10-30 Donald Spector Compositions Useful for Preventing Pain and Soreness Resulting from Exercise and Methods of Use
WO2012148023A1 (ko) * 2011-04-29 2012-11-01 바이올시스템즈 주식회사 무수갈락토스의 분리정제 방법
KR101489732B1 (ko) * 2013-03-15 2015-02-04 고려대학교 산학협력단 3,6-안하이드로-l-갈락토오스를 포함하는 대장암 예방 또는 치료용 조성물
KR102608602B1 (ko) * 2020-11-27 2023-12-01 (주)헬스코치생명공학 Ahg를 이용한 자외선에 의한 피부 주름 개선용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62210958A (ja) 1986-03-13 1987-09-17 Meiji Seika Kaisha Ltd 澱粉含有組成物の老化防止方法
JP3193480B2 (ja) * 1992-09-03 2001-07-30 石原産業株式会社 免疫機能抑制剤
JPH0892303A (ja) * 1994-09-20 1996-04-09 Showa Sangyo Co Ltd 新規な糖、その製造方法および免疫賦活剤
CA2206611A1 (en) * 1994-12-01 1996-06-06 Kiyoshi Morikawa Keratan sulfate oligosaccharide fraction and pharmaceutical containing the same
GB9613722D0 (en) 1996-06-28 1996-08-28 Univ Liverpool Chemical compounds
KR20000071039A (ko) 1997-02-13 2000-11-25 비숍 찰스 더블유. 비타민 ｄ 화합물의 표적화된 치료학적 전달
EA004148B1 (ru) * 1997-11-11 2004-02-26 Такара Сузо Ко., Лтд Фармацевтическая композиция на основе 3,6-ангидрогалактопиранозы, и/или ее производных, и/или растворимого сахарида, содержащего данное соединение, применение композиции и входящих в ее состав ингредиентов, пищевой продукт, содержащий указанную композицию, и применение пищевого продукта
AU3651199A (en) 1998-04-22 1999-11-08 Guennadi V. Glinskii Synthetic glycoamines and methods for their use, alone or in combination with other therapies, that affect cell adhesion, inhibit cancer cell growth and metastasis, and induce apoptosis
US6121253A (en) 1998-11-20 2000-09-19 Merck Frosst Canada & Co. Prostaglandin conjugates for treating or preventing bone disease

Also Published As

Publication number Publication date
EP1146050A1 (de) 2001-10-17
DE60043497D1 (de) 2010-01-21
KR100593393B1 (ko) 2006-06-28
KR20010089810A (ko) 2001-10-08
AU2005400A (en) 2000-08-07
JP4145494B2 (ja) 2008-09-03
WO2000043407A1 (en) 2000-07-27
EP1146050A4 (de) 2002-07-24
EP1146050A9 (de) 2001-12-05
TWI290144B (en) 2007-11-21
CN1344271A (zh) 2002-04-10
CN1210285C (zh) 2005-07-13
US6518302B1 (en) 2003-02-11
EP1146050B1 (de) 2009-12-09

Similar Documents

Publication Publication Date Title
ATE350036T1 (de) Tetrahydroquinolin-derivate
EP0731106A4 (de) Neue peptid-derivate
DE69803907D1 (de) Fungizide 2-Methoxybenzophenone
ATE348608T1 (de) Ep4 rezeptor ligand und verwendung gegen neuropatischen schmerzen, colon krebs, hiv und migräne
ATE278661T1 (de) Anthranilsäurederivate
DE69637717D1 (de) Pyridonkarbonsaüre Derivate und deren Verwendung als antibakterielle Wirkstoffe
IL111184A0 (en) Inclusion complex
DE60043497D1 (de) 4-Substituierte-3,6-Anhydro-Galaktosederivate und ihre pharmazeutische Verwendung
DK0613687T3 (da) Anvendelse af pregnanderivat til behandling af tumorer
ES2129123T3 (es) Nuevo derivado de bisoxadiazolidina.
ES2106058T3 (es) Derivados de benzamida.
DE69512310D1 (de) Glukopyranosid-Benzothiophene
ATE252537T1 (de) Substituierte 2-hydroxybenzophenone, ihre herstellung, ihre verwendung als fungizide und ihre fungizide zusammensetzungen
DK0627443T3 (da) 3,4-dideoxymycaminosyltylonolidderivat og fremstilling deraf
EP1186616A4 (de) Antifucoidan antikörper
DE69706950D1 (de) Furoindolizine
ATE448198T1 (de) Neue alpha-ketoamidderivate und deren verwendung
ATE242227T1 (de) Tetrahydrofuranderivate
DK0810223T3 (da) Adamantylsubstituerede oxindoler som farmaceutiske midler

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties